Search Results | Pediatrics | American Academy of Pediatrics

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Pertussis Vaccine Effectiveness in the Setting of Pertactin-Deficient Pertussis

Lucy Breakwell, PhD, Patsy Kelso, PhD, Christine Finley, APRN, Susan Schoenfeld, RN, Brant Goode, RN ...

Pediatrics (2016) 137 (5): e20153973.

Published: May 2016

View article

Includes: Supplementary data

Journal Articles

Pertussis Pseudo-outbreak Linked to Specimens Contaminated by Bordetella pertussis DNA From Clinic Surfaces

Sema Mandal, MBBS, Kathleen M. Tatti, PhD, Denise Woods-Stout, BA, Pamela K. Cassiday, MS, Amanda E. Faulkner, MPH ...

Pediatrics (2012) 129 (2): e424–e430.

Published: February 2012

View article

Journal Articles

Impact of Rapid Leukodepletion on the Outcome of Severe Clinical Pertussis in Young Infants

Helen E. Rowlands, MBBS, Allan P. Goldman, MBBChB, Karen Harrington, MD, Ann Karimova, MD, Joe Brierley, MBChB ...

Pediatrics (2010) 126 (4): 816–827.

Published: October 2010

View article

Includes: Supplementary data

Journal Articles

Cherry Picking: In Reply

James D. Cherry, MD, MSc

Pediatrics (2005) 116 (4): 1056–1057.

Published: October 2005

View article

Journal Articles

The Epidemiology of Pertussis: A Comparison of the Epidemiology of the Disease Pertussis With the Epidemiology of Bordetella pertussis Infection

James D. Cherry, MD, MSc

Pediatrics (2005) 115 (5): 1422–1427.

Published: May 2005

View article

Journal Articles

Pertussis Pneumonia, Hypoxemia, Hyperleukocytosis, and Pulmonary Hypertension: Improvement in Oxygenation After a Double Volume Exchange Transfusion

Michael J. Romano, MD, Mark D. Weber, RN, CPNP, Martin E. Weisse, MD, Benjamin L. Siu, MD

Pediatrics (2004) 114 (2): e264–e266.

Published: August 2004

View article

Journal Articles

Azithromycin Is as Effective as and Better Tolerated Than Erythromycin Estolate for the Treatment of Pertussis

Joanne M. Langley, MD, Scott A. Halperin, MD, François D. Boucher, MD, Bruce Smith, PhD, Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC)

Pediatrics (2004) 114 (1): e96–e101.

Published: July 2004

View article

Journal Articles

A Controlled Study of the Relationship Between Bordetella pertussis Infections and Sudden Unexpected Deaths Among German Infants

Ulrich Heininger, MD, Werner J. Kleemann, MD, James D. Cherry, MD, MSc, Sudden Infant Death Syndrome Study Group

Pediatrics (2004) 114 (1): e9–e15.

Published: July 2004

View article

Journal Articles

Immunologic and Epidemiologic Experience of Vaccination With a Monocomponent Pertussis Toxoid Vaccine

John Taranger, MD, Birger Trollfors, MD, Elisabet Bergfors, MD, Nina Knutsson, RN, Teresa Lagergård, PhD ...

Pediatrics (2001) 108 (6): e115.

Published: December 2001

View article

Journal Articles

Sustained Efficacy During the First 6 Years of Life of 3-Component Acellular Pertussis Vaccines Administered in Infancy: The Italian Experience

Stefania Salmaso, DBiol, Paola Mastrantonio, PhD, Alberto E. Tozzi, MD, Paola Stefanelli, DBiol, Alessandra Anemona, DStat ...

Pediatrics (2001) 108 (5): e81.

Published: November 2001

View article

Journal Articles

Clinical Validation of a Polymerase Chain Reaction Assay for the Diagnosis of Pertussis by Comparison With Serology, Culture, and Symptoms During a Large Pertussis Vaccine Efficacy Trial

Ulrich Heininger, MD, Gabriela Schmidt-Schläpfer, PhD, James D. Cherry, MD, Klemens Stehr, MD

Pediatrics (2000) 105 (3): e31.

Published: March 2000

View article

Journal Articles

The Science and Fiction of Pertussis Vaccines

James D. Cherry, MD, Patrick Olin, MD

Pediatrics (1999) 104 (6): 1381–1383.

Published: December 1999

View article

Journal Articles

A Randomized, Placebo-Controlled Trial of Erythromycin Estolate Chemoprophylaxis for Household Contacts of Children With Culture-Positive Bordetella pertussis Infection

Scott A. Halperin, MD, R. Bortolussi, MD, Joanne M. Langley, MD, Brian J. Eastwood, PhD, Gaston De Serres, MD

Pediatrics (1999) 104 (4): e42.

Published: October 1999

View article

Journal Articles

Pertussis Encephalopathy With High Cerebrospinal Fluid Antibody Titers to Pertussis Toxin and Filamentous Hemagglutinin

Cameron C. Grant, FRACP, E. John McKay, Dr Med Sci, Alan Simpson, MBChB, David Buckley, FFICANZCA

Pediatrics (1998) 102 (4): 986–989.

Published: October 1998

View article

Journal Articles

Comparative Efficacy of the Lederle/Takeda Acellular Pertussis Component DTP (DTaP) Vaccine and Lederle Whole-Cell Component DTP Vaccine in German Children After Household Exposure

Ulrich Heininger, MD, James D. Cherry, MD, Klemens Stehr, MD, Sabina Schmitt-Grohé, MD, Michael Überall, MD ...

Pediatrics (1998) 102 (3): 546–553.

Published: September 1998

View article

Journal Articles

A Comparative Efficacy Trial in Germany in Infants Who Received Either the Lederle/Takeda Acellular Pertussis Component DTP (DTaP) Vaccine, the Lederle Whole-Cell Component DTP Vaccine, or DT Vaccine

Klemens Stehr, MD, James D. Cherry, MD, Ulrich Heininger, MD, Sabina Schmitt-Grohé, MD, Michael Überall, MD ...

Pediatrics (1998) 101 (1): 1–11.

Published: January 1998

View article

Journal Articles

Clinical Findings in Bordetella pertussis Infections: Results of a Prospective Multicenter Surveillance Study

Ulrich Heininger, MD, Kerstin Klich, MD, Klemens Stehr, MD, James D. Cherry, MD

Pediatrics (1997) 100 (6): e10.

Published: December 1997

View article

Journal Articles

Seven Days of Erythromycin Estolate Is as Effective as Fourteen Days for the Treatment of Bordetella pertussis Infections

Scott A. Halperin, MD, R. Bortolussi, MD, Joanne M. Langley, MD, Barbara Miller, RN, Brian J. Eastwood, PhD

Pediatrics (1997) 100 (1): 65–71.

Published: July 1997

View article

Journal Articles

Letters to the Editor

Margaret A. Keller

Pediatrics (1981) 68 (1): 149.

Published: July 1981

View article

Journal Articles

Antibiotics and Their Effect on Bordetella pertussis in the Nasopharynx

Peter J. Adasek, Marie N. Meyer, C. George Ray

Pediatrics (1969) 44 (4): 606–609.

Published: October 1969

View article

NARROW

Pertussis Vaccine Effectiveness in the Setting of Pertactin-Deficient Pertussis

Pertussis Pseudo-outbreak Linked to Specimens Contaminated by Bordetella pertussis DNA From Clinic Surfaces

Impact of Rapid Leukodepletion on the Outcome of Severe Clinical Pertussis in Young Infants

Cherry Picking: In Reply

The Epidemiology of Pertussis: A Comparison of the Epidemiology of the Disease Pertussis With the Epidemiology of Bordetella pertussis Infection

Pertussis Pneumonia, Hypoxemia, Hyperleukocytosis, and Pulmonary Hypertension: Improvement in Oxygenation After a Double Volume Exchange Transfusion

Azithromycin Is as Effective as and Better Tolerated Than Erythromycin Estolate for the Treatment of Pertussis

A Controlled Study of the Relationship Between Bordetella pertussis Infections and Sudden Unexpected Deaths Among German Infants

Immunologic and Epidemiologic Experience of Vaccination With a Monocomponent Pertussis Toxoid Vaccine

Sustained Efficacy During the First 6 Years of Life of 3-Component Acellular Pertussis Vaccines Administered in Infancy: The Italian Experience

Clinical Validation of a Polymerase Chain Reaction Assay for the Diagnosis of Pertussis by Comparison With Serology, Culture, and Symptoms During a Large Pertussis Vaccine Efficacy Trial

The Science and Fiction of Pertussis Vaccines

A Randomized, Placebo-Controlled Trial of Erythromycin Estolate Chemoprophylaxis for Household Contacts of Children With Culture-Positive Bordetella pertussis Infection

Pertussis Encephalopathy With High Cerebrospinal Fluid Antibody Titers to Pertussis Toxin and Filamentous Hemagglutinin

Comparative Efficacy of the Lederle/Takeda Acellular Pertussis Component DTP (DTaP) Vaccine and Lederle Whole-Cell Component DTP Vaccine in German Children After Household Exposure

A Comparative Efficacy Trial in Germany in Infants Who Received Either the Lederle/Takeda Acellular Pertussis Component DTP (DTaP) Vaccine, the Lederle Whole-Cell Component DTP Vaccine, or DT Vaccine

Clinical Findings in Bordetella pertussis Infections: Results of a Prospective Multicenter Surveillance Study

Seven Days of Erythromycin Estolate Is as Effective as Fourteen Days for the Treatment of Bordetella pertussis Infections

Letters to the Editor

Antibiotics and Their Effect on Bordetella pertussis in the Nasopharynx

Email alerts

Journals

Books

News

Solutions

Policy

Licensing & Permissions

Advertising

Email alerts

Journals

News

Solutions

This Feature Is Available To Subscribers Only